Abstract

Background

As a result of the COVID-19 pandemic, many vaccines were developed to counter the disease, including the vector-based Sputnik V vaccine. The aim of this study is to identify the side effects of the Sputnik V COVID–19 vaccine in a medical center and compare the results with the previous reports.

Methods

A questionnaire-based study was performed after the injection of the first and second doses of the vaccine to assess the side effects experienced by the participants. Through examination of previous similar studies was performed.

Results

Injection site pain, muscle pain, fever, fatigue, chills, and headache were the most common side effects of the vaccine. The incidence of main side effects decreased with age and was lower in the male gender. In our study and some others, the incidence of side effects decreased at the second dose. In some studies, participants with previous history of SARSCOV-2 infection developed more side effects, especially injection site pain, muscle pain, and fatigue.

Conclusions

Most studies agree with our reported results. This vaccine's serious side effects are rare and may be considered tolerable in adults.

Keywords: Side effects COVID-19 Gam-COVID-Vac vaccine Sputnik V COVID-19 Vaccines SARSCOV-2 How to Cite

Eftekharian, K., Eftekharian, A., Alavi Darazam, I., Gachkar, L., Panahi, S., Davoodi, F., Babamohamadi Esfand Abadi, Z., & Fazli, M. (2022). Side Effects Of The Sputnik V Covid-19 Vaccine; Our Experience And A Review Of The Literature: Side effects of Sputnik V vaccine . International Journal of Medical Toxicology and Forensic Medicine, 12(4). https://doi.org/10.32598/ijmtfm.v12i4.38573

References

1. WHO coronavirus disease (COVID-19) dashboard. https://covid19.who.int/ (2022). Accessed April 29, 2022.
2. WHO - The different types of COVID-19 vaccines. https://www.who.int/news-room/feature-stories/detail/the-race-for-a-covid-19-vaccine-explained. Accessed April 29, 2022.
3. WHO side Effects of COVID-19 Vaccines. https://www.who.int/news-room/feature-stories/detail/side-effects-of-covid-19-vaccines. Accessed April 29, 2022.
4. Logunov DY, Dolzhikova IV, Shcheblyakov DV, Tukhvatulin AI, Zubkova OV, Dzharullaeva AS, et al. Gam-COVID-Vac Vaccine Trial Group. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet. 2021 Feb 20;397(10275):671-681. doi: 10.1016/S0140-6736(21)00234-8.
5. Pagotto V, Ferloni A, Mercedes Soriano M, Díaz M, Braguinsky Golde N, González MI, et al. Active monitoring of early safety of Sputnik V vaccine in Buenos Aires, Argentina. Medicina (B Aires). 2021;81(3):408-414.
6. Jarynowski A, Semenov A, Kamiński M, Belik V. Mild Adverse Events of Sputnik V Vaccine in Russia: Social Media Content Analysis of Telegram via Deep Learning J Med Internet Res. 2021 Nov 29;23(11):e30529. doi:10.2196/30529.
7. Zare H, Rezapour H, Mahmoodzadeh S, Fereidouni M. Prevalence of COVID-19 vaccines (Sputnik V, AZD-1222, and Covaxin) side effects among healthcare workers in Birjand city, Iran Int Immunopharmacol. 2021 Dec;101(Pt B):108351. doi: 10.1016/j.intimp.2021.108351.
8. Montalti M, Soldà G, Di Valerio Z, Salussolia A, Lenzi J, Forcellini M, et al. San Marino Republic COVID ROCCA Group. ROCCA observational study: Early results on safety of Sputnik V vaccine (Gam-COVID-Vac) in the Republic of San Marino using active surveillance. EClinicalMedicine. 2021 July 8;38:101027. doi:10.1016/j.eclinm.2021.101027. eCollection 2021 Aug.
9. Zhu FC, Li YH, Guan XH, Hou LH, Wang WJ, Li JX, et al. Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial. Lancet. 2020 June 13;395(10240):1845-1854. doi:10.1016/S0140-6736(20)31208-3. Epub 2020 May 22.
10. Babamahmoodi F, Saeedi M, Alizadeh-Navaei R, Hedayatizadeh-Omran A, Mousavi SA, Ovaise G, et al. Side effects and Immunogenicity following administration of the Sputnik V COVID-19 vaccine in health care workers in Iran. Sci Rep. 2021 Nov 2;11(1):21464. doi:10.1038/s41598-021-00963-7.
11. Houshmand B, Keyhan SO, Fallahi HR, Ramezanzade S, Sadeghi E, Yousefi P. Vaccine-associated complications: a comparative multicenter evaluation among dental practitioners and dental students-which candidate vaccine is more safe in SARS COV II, Gam-COVID-Vac (Sputnik V), ChAdOx1 nCoV-19 (AstraZeneca), BBV152 (Covaxin), or BBIBP-CorV(Sinopharm). Maxillofac Plast Reconstr Surg. 2022 January 13;44(1):3. doi:10.1186/s40902-021-00330-6.
12- Sun Q, Fathy R, McMahon DE, Freeman EE. COVID-19 Vaccines and the Skin: The Landscape of Cutaneous Vaccine Reactions Worldwide. Dermatol Clin. 2021 Oct;39(4):653-673. doi:10.1016/j.det.2021.05.016.

Abstract Viewed: 48 times pdf Downloaded: 5 times